20/04/2024

News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History

20/04/2024

Apr 20, 2024, 08:16 | Blog
Tanja Obradovic: One exciting novel approach is just about to enter clinical development
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc, shared a post on LinkedIn: "Cell…
Apr 20, 2024, 08:11 | Blog
Robin Zon: Great day for Cancer Advocacy!
Robin Zon, President Elect at ASCO and Chair of South Bend Medical Foundation, shared on…
Apr 20, 2024, 08:03 | Blog
Julia Maués: Thank you Dr. Norton for doing what’s right for people with cancer
Julia Maués, Co-Founder of GRASP shared a post on X: “Last but not least, or…
Apr 20, 2024, 07:53 | Career
Ziad Bakouny: I am absolutely thrilled to be joining the editorial team at JCO Clinical Cancer Informatics for a 5-year term as an Associate Editor
Ziad Bakouny, Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center shared a post on X:…
Apr 20, 2024, 07:47 | Drugs
Paper summary by Marco Donia
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Apr 20, 2024, 07:40 | Blog
Qasim Hussaini: Representing Alabama, we met with Representatives Jerry Carl and Gary Palmer to advocate for tele-health
Qasim Hussaini, Medical Oncologist at the Sidney Kimmel Comprehensive Cancer Center of the Johns Hopkins…
Apr 20, 2024, 07:23 | Societies
Join the ASCO Advocacy Summit action virtually using the ACT Network
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: “Join the ASCO Advocacy…
Apr 20, 2024, 07:18 | Societies
Ashley Sumrall: Sending a big thank you to Lynn M. Schuchter and the exceptional ASCO team
Ashley Sumrall shared on X/Twitter: “Sending a big thank you to Lynn M. Schuchter and…
Apr 20, 2024, 07:12 | Insight
Naveen Pemmaraju: Superb clinic team discussions and new ideas
Naveen Pemmaraju shared on X/Twitter: “Superb clinic team discussions and new ideas and patient-centered brainstorming for…
Apr 20, 2024, 07:03 | Drugs
Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP
Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas…
All: 71 Posts: 41 - 50